Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Completed × Edema × Corticotropin-Releasing Hormone × Clear all

Phase

Status

Completed 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Edema 2 Brain Neoplasms 2 Brain Edema 2 Astrocytoma 2

Interventions

Corticotropin-Releasing Hormone 2 Losartan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00088166 2014-08-13

XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors

Celtic Pharma Development Services

Phase 3 Completed

200 enrolled 17 charts

Astrocytoma, Brain Edema, Brain Neoplasms, Edema

NCT00226655 2012-08-31

An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies

Celtic Pharma Development Services

Phase 3 Completed

112 enrolled 8 charts

Astrocytoma, Brain Edema, Brain Neoplasms, Edema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡